Thought Leadership

New ways of thinking in HTA

The EPA conference in Amsterdam was a vibrant gathering of inspiring individuals. In addition to attending the conference, I attended...

14 May 2025

Trump, the NIH, and a possible crisis in health technology assessment

Harry Lewis presents his thoughts on how the cost-cutting approach of the second Trump administration could pose a serious threat...

12 May 2025

NHS England abolition and implications for the pharmaceutical industry

The news that NHSE will be abolished, and its functions rolled in to the Department for Health and Social Care...

29 April 2025

Project Management Excellence in Market Access and Health Economics – Guided by Our Core Values

In the fast-evolving world of market access and health economics, the ability to deliver impactful, evidence-based insights is critical. Success...

26 March 2025

TLV introduces new working methods to increase access to medicines for patients with rare health conditions

The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has introduced new procedures to enhance access to medications for patients with...

9 January 2025

Enhanced Procedural Guidance for JCAs of Medicinal Products

The enhanced procedural guidance for Joint Clinical Assessments (JCAs) aligns with Regulation (EU) 2021/2282 and the Implementing Regulation (IA JCA-MP),...

9 December 2024